Glycemic Control Targets for Diabetic Patients
HbA1c Targets
- The American Diabetes Association recommends maintaining HbA1c levels at <7% for most non-pregnant adults with diabetes, as this target has been shown to reduce microvascular complications and mortality in those with type 1 diabetes 1, 3
- More stringent HbA1c goals (<6.5%) may be appropriate for selected patients with short duration of diabetes, type 2 diabetes treated with lifestyle or metformin only, long life expectancy, or no cardiovascular disease 3, 4
- Less stringent HbA1c goals (<8%) are appropriate for patients with history of severe hypoglycemia, limited life expectancy, advanced microvascular or macrovascular complications, extensive comorbid conditions, or long-standing diabetes 1, 2
Blood Glucose Targets
- The American Diabetes Association recommends preprandial capillary plasma glucose targets of 80-130 mg/dL and peak postprandial capillary plasma glucose targets of <180 mg/dL, measured 1-2 hours after beginning of meal 2
- For pregnant women with gestational diabetes, target glucose values are fasting plasma glucose <95 mg/dL and either 1-hour postprandial <140 mg/dL or 2-hour postprandial <120 mg/dL 4
Factors to Consider When Setting Glycemic Targets
- The American Diabetes Association recommends individualizing glycemic targets based on patient age, with younger patients generally benefiting from more stringent targets, while older patients may have less stringent goals 1, 3
- Disease duration is also a factor, with newly diagnosed patients benefiting more from stringent control compared to those with long-standing diabetes 2
- Life expectancy is another consideration, with patients with longer life expectancy benefiting more from tight control 6
- Comorbidities, such as cardiovascular disease, may warrant less stringent targets 1, 2
Monitoring Frequency
- The American Diabetes Association recommends measuring HbA1c at least twice yearly in patients meeting treatment goals with stable glycemic control, and quarterly in patients whose therapy has changed or who are not meeting glycemic goals 3, 5
- Self-monitoring of blood glucose (SMBG) frequency should be dictated by the individual needs and goals of the patient, with more frequent monitoring recommended for patients on intensive insulin regimens 3, 8
Laboratory Monitoring Beyond Glycemic Control
- Regular monitoring of lipids, kidney function, and urine albumin-to-creatinine ratio is essential for comprehensive diabetes management, according to the American Diabetes Association 9
- For patients prone to ketosis, ketone testing in urine or blood should be performed when unexplained hyperglycemia or symptoms of ketosis occur, and specific measurement of β-hydroxybutyrate in blood is preferred for diagnosis and monitoring of diabetic ketoacidosis 4